-
-
-
-
-
-
-
Nivalis Therapeutics Reports First Quarter 2016 Financial Results
-
-
-
-
-
-
-
Novellus Systems, Inc. (NVLS) Reports In-Line Q1 EPS of 61c
-
-
-
-
-
-
-
Notable Analyst Rating Changes 12/20: (KLAC) (LIFE) (CAM) Upgraded; (T) (OC) (NVLS) Downgraded
-
-
-
-
-
-
-
Needham & Company Reiterates a 'Buy' on Novellus (NVLS); 4Q11 Bookings to Rebound as Customers Resume Investments
-
-
-
-
-
-
-
Needham & Company Maintains a 'Buy' on Novellus (NVLS); Weak Bookings Guidance on Foundry Push-Outs
-
-
-
-
-
-
-
Trading Radar for 01/31: Exxon Mobil (XOM), Gannett (GCI), Baidu.com (BIDU), Sohu.com (SOHU) Report
-
-
-
-
1,199,654 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

